2024 Critical Care Congress Skip to main content
2024 Critical Care Congress Main banner
Back

Infection

Category: 90-Minute Session

Clinical Evidence for Host-Directed Therapeutics

(545085-01) Repurposing Host-Directed Therapeutics for COVID-19

Sunday, January 21, 2024
11:50 AM – 12:00 PM MT
Location: North-120A

    P Speaker(s)

  • Larry Tsai

    VP Global Head of Respiratory, Allergy & Infectious Disease Product Development
    Genentech, Inc.
    South San Francisco, California

Disclosure(s):
Larry Tsai: Genentech: Employee (any industry) (Ongoing), Salary (Ongoing)